Is there a link between erythropoietin therapy and adynamic bone disease ?SMANS, K. A; VAN LANDEGHEM, G. F; D'HAESE, P. C et al.Nephrology, dialysis, transplantation (Print). 1996, Vol 11, Num 7, pp 1248-1249, issn 0931-0509Conference Paper

Haemodialysis-associated anaphylactic and anaphylactoid reactionsEBO, D. G; BOSMANS, J. L; COUTTENYE, M. M et al.Allergy (Copenhagen). 2006, Vol 61, Num 2, pp 211-220, issn 0105-4538, 10 p.Article

Unusual D-lactic acid acidosis from propylene glycol metabolism in overdoseJORENS, Philippe G; DEMEY, Hendrik E; SCHEPENS, Paul J. C et al.Journal of toxicology. Clinical toxicology. 2004, Vol 42, Num 2, pp 163-169, issn 0731-3810, 7 p.Article

Acquired immunodeficiency syndrome mimicking Sjögren's syndrome and systemic lupus erythematosusDE CLERCK, L. S; COUTTENYE, M. M; DE BROE, M. E et al.Arthritis and rheumatism. 1988, Vol 31, Num 2, pp 272-275, issn 0004-3591Article

Functional acute renal failure in a patient with carcinoid syndromeCOUTTENYE, M. M; VERPOOTEN, G. A; DAELEMANS, R. A et al.Nephron. 1987, Vol 47, Num 2, pp 131-133, issn 0028-2766Article

High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD populationCOUTTENYE, M. M; D'HAESE, P. C; DENG, J. T et al.Nephrology, dialysis, transplantation (Print). 1997, Vol 12, Num 10, pp 2144-2150, issn 0931-0509Article

Low serum levels of alkaline phosphatase of bone origin : a good marker of adynamic bone disease in haemodialysis patientsCOUTTENYE, M. M; D'HAESE, P. C; VAN HOOF, V. O et al.Nephrology, dialysis, transplantation (Print). 1996, Vol 11, Num 6, pp 1065-1072, issn 0931-0509Conference Paper

Immunoradiometric method and electrophoretic system compared for quantifying bone alkaline phosphatase in serumVAN HOOF, V. O; MARTIN, M; BLOCKX, P et al.Clinical chemistry (Baltimore, Md.). 1995, Vol 41, Num 6, pp 853-857, issn 0009-9147, 1Article

Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patientsLEFEBURE, A. F; VERPOOTEN, G. A; COUTTENYE, M. M et al.Vaccine. 1993, Vol 11, Num 4, pp 397-399, issn 0264-410XArticle

Effects of prostacyclin on contractile properties of isolated mammalian cardiac muscleCOUTTENYE, M. M; DE CLERK, N. M; HERMAN, A. G et al.Journal of cardiovascular pharmacology. 1985, Vol 7, Num 5, pp 971-976, issn 0160-2446Article

Diagnosis and treatment of aluminium bone diseaseD'HAESE, P. C; COUTTENYE, M.-M; DE BROE, M. E et al.Nephrology, dialysis, transplantation (Print). 1996, Vol 11, pp 74-79, issn 0931-0509, SUP3Conference Paper

New insights and strategies in the diagnosis and treatment of aluminium overload in dialysis patientsDE BROE, M. E; D'HAESE, P. C; COUTTENYE, M.-M et al.Nephrology, dialysis, transplantation (Print). 1993, Vol 8, pp 47-50, issn 0931-0509, SUP1Article

Determination of ionized calcium : Evaluation of sampling and storage proceduresCOUTTENYE, M.-M; JURGENS, A; LAMBERTS, L. V et al.Clinical chemistry (Baltimore, Md.). 1996, Vol 42, Num 3, pp 468-469, issn 0009-9147Article

Increased bone strontium levels in hemodialysis patients with osteomalaciaD'HAESE, P. C; SCHROOTEN, I; GOODMAN, W. G et al.Kidney international. 2000, Vol 57, Num 3, pp 1107-1114, issn 0085-2538Conference Paper

Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patientsD'HAESE, P. C; COUTTENYE, M.-M; LAMBERTS, L. V et al.Clinical chemistry (Baltimore, Md.). 1999, Vol 45, Num 9, pp 1548-1556, issn 0009-9147Conference Paper

Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overloadD'HAESE, P. C; COUTTENYE, M.-M; GOODMAN, W. G et al.Nephrology, dialysis, transplantation (Print). 1995, Vol 10, Num 10, pp 1874-1884, issn 0931-0509Conference Paper